$EGRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in EAGLE PHARMACEUTICALS, INC.. Get notifications about new insider transactions in EAGLE PHARMACEUTICALS, INC. for free.

Page:   1 2 3 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 30 2021EGRXEAGLE PHARMACEUTIC ...BORIO LUCIANADirectorOption ExerciseA41.4213,500559,17013,500
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM4.422,34010,3430
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM8.782,34020,5450
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM8.782,34020,5450
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM4.422,34010,34327,36425 K to 27.4 K (+9.35 %)
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM8.782,34020,54525,02422.7 K to 25 K (+10.32 %)
Apr 12 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM8.782,34020,54522,68420.3 K to 22.7 K (+11.50 %)
Apr 07 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM8.782,34020,5450
Apr 07 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM8.782,34020,54520,34418 K to 20.3 K (+13.00 %)
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Simpson Jennifer K.DirectorOption ExerciseA49.3213,500665,82013,500
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseA49.3213,500665,82013,500
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...GrantA0.009,700054,62544.9 K to 54.6 K (+21.59 %)
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Ng-Cashin JudithChief Medical Offic ...GrantA0.002,00002,0000 to 2 K
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA49.3213,500665,82013,500
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA49.3213,500665,82013,500
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...GrantA0.008,900027,56618.7 K to 27.6 K (+47.68 %)
Feb 04 2021EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorOption ExerciseA49.3213,500665,82013,500
Feb 02 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...Payment of ExerciseF46.6763729,72918,66619.3 K to 18.7 K (-3.30 %)
Jan 26 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF47.701,89290,24844,92546.8 K to 44.9 K (-4.04 %)
Jan 26 2021EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOPayment of ExerciseF47.704,631220,8991,546,3231.6 M to 1.5 M (-0.30 %)
Jan 22 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...Option ExerciseA48.0910,000480,90010,000
Jan 22 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...GrantA0.005,000019,30314.3 K to 19.3 K (+34.96 %)
Jan 11 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...Payment of ExerciseF50.9723712,08014,30314.5 K to 14.3 K (-1.63 %)
Jan 11 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF50.9790646,17946,81747.7 K to 46.8 K (-1.90 %)
Jan 07 2021EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres & Chief Operat ...Payment of ExerciseF50.022,088104,44247,72349.8 K to 47.7 K (-4.19 %)
Jan 07 2021EGRXEAGLE PHARMACEUTIC ...Cahill Brian JosephChief Financial Off ...Payment of ExerciseF50.0274637,31514,54015.3 K to 14.5 K (-4.88 %)
Jan 27 2020EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOPayment of ExerciseF57.987,548437,6331,550,9541.6 M to 1.6 M (-0.48 %)
Jan 27 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF57.981,793103,95849,81151.6 K to 49.8 K (-3.47 %)
Jan 27 2020EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Payment of ExerciseF57.981,63094,50748,78450.4 K to 48.8 K (-3.23 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseA59.80145,7008,712,132145,700
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOGrantA0.0058,30001,558,5021.5 M to 1.6 M (+3.89 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Simpson Jennifer K.DirectorOption ExerciseA59.8010,000597,95010,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseA59.8010,000597,95010,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA59.8051,0003,049,54551,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF57.3890451,87251,60452.5 K to 51.6 K (-1.72 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0021,500052,50831 K to 52.5 K (+69.34 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Option ExerciseA59.8048,0002,870,16048,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Payment of ExerciseF57.3863236,26445,26845.9 K to 45.3 K (-1.38 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...GrantA0.0019,500045,90026.4 K to 45.9 K (+73.86 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Option ExerciseA59.8055,0003,288,72555,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Payment of ExerciseF57.3881546,76550,41451.2 K to 50.4 K (-1.59 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...GrantA0.0024,000051,22927.2 K to 51.2 K (+88.14 %)
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA59.8010,000597,95010,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA59.8010,000597,95010,000
Jan 07 2020EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorOption ExerciseA59.8010,000597,95010,000
Oct 28 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS63.5715,437981,302732,777748.2 K to 732.8 K (-2.06 %)
Oct 28 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS63.5715,437981,302732,777748.2 K to 732.8 K (-2.06 %)
Oct 28 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.531,49493,412748,214749.7 K to 748.2 K (-0.20 %)
Oct 28 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.531,49493,412748,214749.7 K to 748.2 K (-0.20 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.5820012,516749,708749.9 K to 749.7 K (-0.03 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.5820012,516749,708749.9 K to 749.7 K (-0.03 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.686,567411,618749,908756.5 K to 749.9 K (-0.87 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.686,567411,618749,908756.5 K to 749.9 K (-0.87 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.563,849240,791756,475760.3 K to 756.5 K (-0.51 %)
Oct 23 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.563,849240,791756,475760.3 K to 756.5 K (-0.51 %)
Oct 18 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.611,600100,174760,324761.9 K to 760.3 K (-0.21 %)
Oct 18 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.5813,842866,196761,924775.8 K to 761.9 K (-1.78 %)
Oct 18 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.501026,375775,766775.9 K to 775.8 K (-0.01 %)
Oct 15 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS62.633,909244,836775,868779.8 K to 775.9 K (-0.50 %)
Oct 15 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.3916,300984,419779,777796.1 K to 779.8 K (-2.05 %)
Oct 15 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.167,829471,002796,077803.9 K to 796.1 K (-0.97 %)
Oct 10 2019EGRXEAGLE PHARMACEUTIC ...Simpson Jennifer K.DirectorOption ExerciseA58.8810,000588,80010,000
Oct 09 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.031,55893,520803,906805.5 K to 803.9 K (-0.19 %)
Oct 09 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.114,901294,600805,464810.4 K to 805.5 K (-0.60 %)
Sep 19 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.001006,000810,365810.5 K to 810.4 K (-0.01 %)
Sep 13 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.0720012,014810,465810.7 K to 810.5 K (-0.02 %)
Sep 13 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.0720012,014810,465810.7 K to 810.5 K (-0.02 %)
Sep 13 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.061,11266,785810,665811.8 K to 810.7 K (-0.14 %)
Sep 13 2019EGRXEAGLE PHARMACEUTIC ...Hudson Executive Capital LPDirectorSellS60.061,11266,785810,665811.8 K to 810.7 K (-0.14 %)
May 13 2019EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorSellS56.14100,0005,614,000811,777911.8 K to 811.8 K (-10.97 %)
May 13 2019EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorSellS56.14100,0005,614,000811,777911.8 K to 811.8 K (-10.97 %)
May 13 2019EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorSellS57.9559,2233,431,973911,777971 K to 911.8 K (-6.10 %)
May 13 2019EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorSellS57.9559,2233,431,973911,777971 K to 911.8 K (-6.10 %)
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM4.042,3409,4540
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM4.042,3409,45418,00415.7 K to 18 K (+14.94 %)
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM4.042,3409,4540
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM4.042,3409,45418,00415.7 K to 18 K (+14.94 %)
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorOption ExerciseM4.042,3409,4540
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorPayment of ExerciseF48.892049,97413,51013.7 K to 13.5 K (-1.49 %)
Mar 06 2019EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorBuyM4.042,3409,45413,71411.4 K to 13.7 K (+20.57 %)
Mar 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS51.8112,428643,8951,525,1771.5 M to 1.5 M (-0.81 %)
Mar 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS50.5112,000606,1201,537,6051.5 M to 1.5 M (-0.77 %)
Feb 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS42.3090038,0701,549,6051.6 M to 1.5 M (-0.06 %)
Feb 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS41.5229,1851,211,7611,550,5051.6 M to 1.6 M (-1.85 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseA42.40137,2005,817,280137,200
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOGrantA0.0061,30001,579,6901.5 M to 1.6 M (+4.04 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseA42.4010,000424,00010,000
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA42.4046,6001,975,84046,600
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0020,900031,00810.1 K to 31 K (+206.77 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Payment of ExerciseF41.3385835,46110,10811 K to 10.1 K (-7.82 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Option ExerciseA42.4043,2001,831,68043,200
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...GrantA0.0019,300026,4007.1 K to 26.4 K (+271.83 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Payment of ExerciseF41.3360024,7987,1007.7 K to 7.1 K (-7.79 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Option ExerciseA42.4042,5001,802,00042,500
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...GrantA0.0019,000027,2298.2 K to 27.2 K (+230.89 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Payment of ExerciseF41.3377131,8658,2299 K to 8.2 K (-8.57 %)
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA42.4010,000424,00010,000
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA42.4010,000424,00010,000
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorOption ExerciseA42.4010,000424,00010,000
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorOption ExerciseA42.4010,000424,00010,000
Jan 25 2019EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorOption ExerciseA42.4010,000424,00010,000
Jan 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS40.5730212,2521,518,3901.5 M to 1.5 M (-0.02 %)
Jan 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS39.705,670225,0991,518,6921.5 M to 1.5 M (-0.37 %)
Jan 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS39.0410,597413,7071,524,3621.5 M to 1.5 M (-0.69 %)
Jan 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS40.038,500340,2551,534,9591.5 M to 1.5 M (-0.55 %)
Jan 04 2019EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOSellS39.306,500255,4501,543,4591.5 M to 1.5 M (-0.42 %)
Jul 03 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseM4.04124,804504,2080
Jul 03 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOBuyM4.04124,804504,2081,549,9591.4 M to 1.5 M (+8.76 %)
Apr 03 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseM4.04113,104456,9400
Apr 03 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOPayment of ExerciseF52.6957,8953,050,4881,425,1551.5 M to 1.4 M (-3.90 %)
Apr 03 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOBuyM4.04113,104456,9401,483,0501.4 M to 1.5 M (+8.26 %)
Mar 07 2018EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorOption ExerciseM0.902,3402,1060
Mar 07 2018EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorSellS53.942,340126,22011,37413.7 K to 11.4 K (-17.06 %)
Mar 07 2018EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorBuyM0.902,3402,10613,71411.4 K to 13.7 K (+20.57 %)
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseA0.00189,0000189,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Tarriff ScottCEOOption ExerciseA59.14157,0009,284,980157,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseA59.1410,000591,40010,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA0.0030,000030,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...Option ExerciseA59.1450,0002,957,00050,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...GrantA0.0010,000010,966966 to 11 K (+1,035.20 %)
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Option ExerciseA0.0021,000021,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Option ExerciseA59.1437,0002,188,18037,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...GrantA0.007,00007,700700 to 7.7 K (+1,000.00 %)
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseA0.009,00009,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...Option ExerciseA59.1415,000887,10015,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Krill Steven L.EVP & Chief Scienti ...GrantA0.003,00003,0000 to 3 K
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Option ExerciseA0.0027,000027,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...Option ExerciseA59.1443,0002,543,02043,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Hepner AdrianEVP and Chief Medic ...GrantA0.009,00009,0000 to 9 K
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Graves MichaelDirectorOption ExerciseA59.1410,000591,40010,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Glenning RobertDirectorOption ExerciseA59.1410,000591,40010,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...FLAUM SANDER ADirectorOption ExerciseA59.1410,000591,40010,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Edlin Richard A.DirectorOption ExerciseA59.1410,000591,40010,000
Jan 09 2018EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorOption ExerciseA59.1410,000591,40010,000
Dec 20 2017EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorOption ExerciseM0.902,3402,1060
Dec 20 2017EGRXEAGLE PHARMACEUTIC ...RATOFF STEVEN BDirectorBuyM0.902,3402,10615,66413.3 K to 15.7 K (+17.56 %)
Aug 16 2017EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...BuyP55.4535019,406700350 to 700 (+100.00 %)
Aug 11 2017EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorBuyP50.091,58479,338971,000969.4 K to 971 K (+0.16 %)
Aug 11 2017EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorBuyP49.2115,206748,258969,416954.2 K to 969.4 K (+1.59 %)
Aug 11 2017EGRXEAGLE PHARMACEUTIC ...Braunstein Douglas LDirectorBuyP48.063,610173,490954,210950.6 K to 954.2 K (+0.38 %)
Jun 12 2017EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...BuyP71.4935025,0213500 to 350
May 19 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP79.6925520,321966711 to 966 (+35.86 %)
May 16 2017EGRXEAGLE PHARMACEUTIC ...Pernock DavidPres. & Chief Comm. ...BuyP82.2420016,448711511 to 711 (+39.14 %)
May 15 2017EGRXEAGLE PHARMACEUTIC ...Meyers Pete A.Chief Financial Off ...Option ExerciseA82.3050,0004,115,00050,000
May 15 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerBuyJ0.00149,1070149,1070 to 149.1 K
May 15 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerBuyJ0.00149,1070172,38123.3 K to 172.4 K (+640.66 %)
May 15 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellJ0.003,584,087003.6 M to 0 (-100.00 %)
Apr 03 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.1361,4205,105,8453,584,0873.6 M to 3.6 M (-1.68 %)
Apr 03 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.0223,6891,966,6613,645,5073.7 M to 3.6 M (-0.65 %)
Apr 03 2017EGRXEAGLE PHARMACEUTIC ...ProQuest Investments IV, L.P.10% OwnerSellS83.006,223516,5093,669,1963.7 M to 3.7 M (-0.17 %)

Page:   1 2 3 next >

Contact us | Follow us on Twitter